How did ELV's Q4 2024 earnings surprise investors?
4/5/2025 01:26pm
Elevance Health (ELV) experienced a negative earnings surprise in Q4 2024, as evidenced by the EPS Surprise of -0.14, which indicates that the actual EPS was below market expectations.
This negative surprise is consistent with the challenges the company faced, including ongoing challenges in the Medicaid business and strategic initiatives aimed at improving profitability. The company's GAAP EPS for Q3 2024 was $4.36, which reflected these challenges and contributed to the earnings miss. Despite revenue growth and a slight increase in the Benefit Expense Ratio, the market's reaction to the earnings report was negative, as indicated by the 5.26% decrease in the stock price following the earnings release.